Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Ondansetron ODT
Medication labelWhy this: Advisory · dailymed-prescription
Ondansetron is indicated for the prevention of nausea and vomiting associated with: • highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2 • initial and repeat courses of moderately emetogenic cancer chemotherapy • radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron is also indicated for the prevention of postoperative nausea and/or vomiting.
- generic_name
- ondansetron
- product_names
- Ondansetron
- ndc
- 80425-0222, 68462-158, 80425-0222-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en